Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D015107:4-Butyrolactone / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D003342:Corpus Striatum / Q000502:physiology*; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D008297:Male; D008972:Molindone / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000502:physiology*; D013239:Stereotyped Behavior / Q000187:drug effects
D011954:Receptors, Dopamine; D015102:3,4-Dihydroxyphenylacetic Acid; D000661:Amphetamine; D001058:Apomorphine; D015107:4-Butyrolactone; D008972:Molindone; D006719:Homovanillic Acid